A detailed history of Squarepoint Ops LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 146,957 shares of GOSS stock, worth $129,322. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146,957
Holding current value
$129,322
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.79 - $1.25 $116,096 - $183,696
146,957 New
146,957 $145,000
Q1 2024

May 15, 2024

BUY
$0.8 - $1.51 $202,874 - $382,925
253,593 Added 546.05%
300,034 $354,000
Q4 2023

Feb 14, 2024

SELL
$0.48 - $1.08 $49,738 - $111,911
-103,622 Reduced 69.05%
46,441 $42,000
Q2 2023

Aug 14, 2023

SELL
$0.98 - $1.53 $499,664 - $780,088
-509,862 Reduced 77.26%
150,063 $180,000
Q1 2023

May 15, 2023

SELL
$0.96 - $2.92 $244,800 - $744,602
-255,001 Reduced 27.87%
659,925 $831,000
Q4 2022

Feb 14, 2023

BUY
$1.74 - $12.87 $1.17 Million - $8.68 Million
674,380 Added 280.35%
914,926 $1.99 Million
Q3 2022

Nov 14, 2022

BUY
$7.21 - $14.88 $1.5 Million - $3.09 Million
207,985 Added 638.75%
240,546 $2.88 Million
Q2 2022

Aug 15, 2022

SELL
$5.97 - $9.97 $108,570 - $181,314
-18,186 Reduced 35.84%
32,561 $273,000
Q1 2022

May 16, 2022

BUY
$8.44 - $12.49 $428,304 - $633,830
50,747 New
50,747 $440,000
Q3 2021

Nov 15, 2021

SELL
$7.25 - $13.23 $76,668 - $139,907
-10,575 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$8.0 - $9.75 $156,904 - $191,226
-19,613 Reduced 64.97%
10,575 $86,000
Q1 2021

May 17, 2021

SELL
$8.63 - $10.94 $206,507 - $261,783
-23,929 Reduced 44.22%
30,188 $279,000
Q4 2020

Feb 16, 2021

BUY
$8.3 - $13.59 $330,597 - $541,303
39,831 Added 278.81%
54,117 $523,000
Q3 2020

Nov 16, 2020

BUY
$11.3 - $14.75 $4,440 - $5,796
393 Added 2.83%
14,286 $177,000
Q2 2020

Aug 14, 2020

SELL
$9.52 - $15.98 $42,173 - $70,791
-4,430 Reduced 24.18%
13,893 $181,000
Q1 2020

May 15, 2020

SELL
$8.0 - $15.48 $120,912 - $233,964
-15,114 Reduced 45.2%
18,323 $186,000
Q4 2019

Feb 14, 2020

BUY
$14.82 - $26.79 $495,536 - $895,777
33,437 New
33,437 $523,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $82.7M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.